Parkinson's disease trials recruiting in Pennsylvania

All Parkinson's disease trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
  NCT06565195 · Phase: Phase 1 · Ages: 30 Years to 80 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
  NCT06680830 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
  NCT05539196 · Phase: Not specified · Ages: 30 Years to 99 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
  NCT06285643 · Phase: Phase 2 · Ages: 45 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Study of Buntanetap in Participants With PD
  NCT07284784 · Phase: Phase 2, Phase 3 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Pennsylvania: Willow Grove
• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
  NCT07174310 · Phase: Phase 3 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh
• A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
  NCT07330258 · Phase: Not specified · Ages: 45 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)
  NCT05070013 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Biofluid Research on Age-Related or Inherited Neurodegeneration
  NCT07798700 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
  NCT07265596 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
  NCT07064005 · Phase: Phase 1 · Ages: 50 Years to 80 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Impact of a Biophoton Therapy on Patients With Brain Disorders
  NCT06147999 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Butler
• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
  NCT04477785 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh
• Parkinson's Disease and Movement Disorders Clinical Database
  NCT04997642 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• Parkinson's Foundation PD GENEration Genetic Registry
  NCT04994015 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh
• Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
  NCT04373317 · Phase: Phase 4 · Ages: 40 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
  NCT06303921 · Phase: Early Phase 1 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Pennsylvania: Philadelphia